𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma

✍ Scribed by Tsai, J. F.; Jeng, J. E.; Chuang, L. Y.; You, H. L.; Wang, L. Y.; Hsieh, M. Y.; Chen, S. C.; Chuang, W. L.; Lin, Z. Y.; Yu, M. L.; Dai, C. Y.

Book ID
120562093
Publisher
Informa plc
Year
2005
Tongue
English
Weight
132 KB
Volume
40
Category
Article
ISSN
0036-5521

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Transforming growth factor-Ξ²1 as a usefu
Transforming growth factor-Ξ²1 as a useful serologic marker of small hepatocellular carcinoma
✍ Byung-Cheol Song; Young-Hwa Chung; Jung A. Kim; Won-Beom Choi; Dong Dae Suh; Seu πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Abstract ## BACKGROUND Although alpha‐fetoprotein (AFP) is a useful serologic marker of hepatocellular carcinoma (HCC), it has been reported insufficiently sensitive in detecting small HCCs. Plasma transforming growth factor‐β1 (TGFΞ²1) has been reported to be elevated in HCC patients compared w

Serum transforming growth factor Ξ± level
Serum transforming growth factor Ξ± level as a marker of hepatocellular carcinoma complicating cirrhosis
✍ Tomoaki Tomiya; Kenji Fujiwara πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 360 KB πŸ‘ 1 views

Transforming growth factor u (TGFn) is alleged to play a role in malignant progression as well as normal cell growth in an autocrine manner and its serum levels have been reported to increase during this progression. Most hepatocellular carcinomas (HCC) develop in cirrhotic livers in which hepatocyt